Continued concerns about geopolitical developments sent the markets down to a lower close with the Dow dropping 59 points to 20,591. Nasdaq tumbled 30 points to 5,836.
On the upside
The Food and Drug Administration approved Neurocrine Biosciences' (Nasdaq: NBIX) Ingrezza as the first and only treatment for adults with tardive dyskinesia.
DryShips (Nasdaq: DRYS) entered a one year contract for a grain house to use one of its 206,000 dwt Newcastlemax drybulk vessels.
China Techfaith Wireless Communication Technology (Nasdaq: CNTF) reported sharply higher earnings and revenue for the second half of 2016.
On the downside
WAVE Life Sciences (Nasdaq: WVE) priced its public offering of approximately 4.167 million common shares at the discounted price of $24.00 per share.
Shares of Netshoes (NYSE: NETS) fell on its first trading day.
ClubCorp (NYSE: MYCC) reported a loss for the first quarter, announced the retirement of chief executive Eric Affeldt, acquired the Oakhurst Golf & Country Club, and ended efforts to sell the company.
In the broad market, declining issues outpaced advancers by a margin of more than 2 to 1 on both the NYSE and on Nasdaq. The broader S&P 500 index fell 8 points to 2,344. Bitcoin dropped $8 to $1210.
